September 9th 2025
Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.
September 2nd 2025
Dry eye specialists weigh in on what role dry eye plays in their practices.
August 8th 2025
New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with minimal treatments over 2 years.
August 7th 2025
TearCare is associated with greater health utility over time but also resulted in significant cost savings compared with CsA.
August 4th 2025
Due to ubiquity, optometrists tend to undertreat patients with dry eye.
Q&A: How to start the dry eye conversation with patients
Maria Sampalis, OD, shares how she approaches starting the dry eye conversation when diagnosing her patients.
Q&A: Common visual habits that lead to dry eye
Maria Sampalis, OD, shares the common habits her dry eye patients have that lead them to developing the disease.
Dry eye appears in an unlikely subject
Canine patient case study reveals a surprising diagnosis
"What you must know about eyestrain" promises a path to comfortable vision
New book offers guidelines for understanding and eliminating symptoms of eyestrain.
Johnson & Johnson Vision introduces next-gen MGD treatment following positive study outcomes
New activator features a single-piece eye cup and translucent design that allows for more efficient and accurate positioning in the eye.
Poll: When do you educate your patients about allergic conjunctivitis?
Check out our latest poll!
The double standard of clinical care: Do as I say, not as I do
Michael Brown, OD, MHS-CL, FAAO reflects on how, sometimes, doctors fail to practice what they preach
Poll: Do your dry eye patients require additional treatment during allergy season?
Alcon partners with actress Kate Walsh on US launch of Systane dry eye drops
The partnership is in support of the company's latest dry eye relief campaign and part of the launch for its leading global artificial tear drop brand.
Higher risk of dry eye disease linked to post-COVID-19 patients
Fully recovered COVID-19 patients have a higher prevalence for developing dry eye disease, researchers report.
Alcon introduces new medical device for dry eye treatment
As an all-in-one handheld device, eyecare practitioners can tailor patients’ needs for MGD treatment in both eyes in approximately 8 to 12 minutes.
Optic relief: Medusa eye exam
Check out this week's cartoon!
Tackling the problem of contact lens dropout from presbyopia
With advanced, easy-to-fit multifocal lens technologies, patients don’t need to compromise
Real-world feedback on nasal spray DED treatment
Carly Rose, OD, FAAO, shares her experience and patient feedback on implementing the first and only FDA-approved nasal spray for dry eye treatment.
SECO 2022 in review: findings presented in New Orleans
SECO hosted its 2022 annual meeting March 9-13 at the Ernest N. Morial Convention Center with a LIVE CE virtual meeting available to online attendees.
Restoring sight against all odds
Clinical trial launch proves transformative for one optometrist’s career
The ocular surface and makeup: What you need to know
Pamela Theriot OD, FAAO, on highlights from her SECO 2022 presentation "Makeup and the ocular surface: what you need to know"
Combatting dry eye during contact lens wear
Tools and therapies for dry eye with contact lens wear
It’s not just about the eyes but the skin too
Optometrists at the forefront of ocular basal cell and squamous cell carcinomas
Adding intense pulsed light to your practice
Selina McGee, OD, FAAO, disscusses her SECO 2022 presentation "See the light! Adding IPL to your practice."
Kala Pharmaceuticals: EYSUVIS now covered on UnitedHealthcare Commercial, Cigna Medicare
Effective this month, the coverage applies to approximately 70% of all United Healthcare commercial lives.
6 daily habits destroying your eyes
These habits wreak havoc on your vision
Identifying ocular surface medicamentosa apart from ocular allergies
Address key factors and causes to ensure a proper diagnosis and treatment plan
Aramis Biosciences doses first patient in phase 2 trial for DED treatment
Topline proof-of-concept data are expected by the first quarter of 2023.
Pregnancy and postpartum ophthalmic changes can present a challenge
Serious pathologies require high index of suspicion for diagnosis, management
Oyster Point Pharma’s nasal spray for DED now covered by Express Scripts
TRYVAYA is the first and only FDA-approved nasal spray for the treatment of dry eye disease.
Dry eye disease onset at a younger age
Screen time affecting millennials’ eye health.
Lumenis partners with Mandy Moore on DED awareness
The actress and singer-songwriter will serves as the brand ambassador for OptiLight, a new dry eye disease treatment.
TearClear’s TC-002 Latanoprost Ophthalmic Solution begins Phase 3 trial
The removal of preservatives may be beneficial for the ocular health of glaucoma patients
FDA approves generic cyclosporine ophthalmic emulsion for DED
The FDA announced approval of the first generic version of Restasis (cyclosporine ophthalmic emulsion) 0.05% eye drops Thursday.